Divestments

Aldevron

The leading global supplier of plasmid DNA used in cell and gene therapies

Aldevron is the leading global supplier of GMP, GMP-SourceTM and Research Grade plasmid DNA used in commercial, clinical and research stage gene therapies, as well as proteins, antibodies and mRNA.

  • Sektor
    Healthcare
  • Land
    United States
  • Ansvarig Advisor
    Eric Liu
  • Fond
    EQT VIII
  • Entry
    2019
  • Web
  • Exit
    2021-08-30
  • Societal Contribution

  • 3Good health and well-being
  • 9Industry, innovation and infrastructure
  • 12Responsible consumption and production

About Aldevron
Founded in 1998 by Michael Chambers and John Ballantyne, Aldevron is the leading global supplier of GMP, GMP-SourceTM and Research Grade plasmid DNA used in commercial, clinical and research stage gene therapies, as well as proteins, antibodies and mRNA. The company’s mission is to develop and manufacture biologics at the highest quality that help make meaningful changes worldwide, and its custom development and manufacturing capabilities enable scientists to develop groundbreaking new therapies. Aldevron is based in Fargo, North Dakota and has additional operations in Madison, Wisconsin and Freiburg, Germany. The Company serves leading academic and research institutions, pharmaceutical and biotechnology companies.

Prenumerera

Prenumerera på EQT:s press releaser, regulatoriska press releaser och updates.

Typ av nyheter
Preferred language
EQT logo
En syftesdriven global investeringsorganisation
© EQT AB 2021. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180